Topic: R&D
-
Ethics of Clinical Trials to Evaluate Biosimilars
-
Time to Throw in the Towel on Biosimilars
-
Mortgaging New Treatments Kicks the Can on High Drug Prices
-
US Drug Prices And R&D, Take 2: A Reply To Grabowski And Manning, And To Light
-
R&D Costs Do Not Explain Elevated U.S. Drug Prices
-
Targeted Drugs for Metastatic Renal Cell Carcinoma